Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression

INTRODUCTION: Schizophrenia increases the risk of mortality and cardiovascular disease (CVD) risk. However, the correlation between antipsychotics (APs) and CVD remains controversial. Hyperlipidemia is a significant risk factor for CVD. METHODS: We conducted a nationwide population-based retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tien-Yuan, Tien, Ni, Lin, Cheng-Li, Cheah, Yu-Cun, Hsu, Chung Y., Tsai, Fuu-Jen, Fang, Yi-Jen, Lim, Yun-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324036/
https://www.ncbi.nlm.nih.gov/pubmed/37425327
http://dx.doi.org/10.3389/fmed.2023.1137977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324036/
https://www.ncbi.nlm.nih.gov/pubmed/37425327
http://dx.doi.org/10.3389/fmed.2023.1137977

Ejemplares similares